Literature DB >> 8252471

Prognostic value of DNA analysis in colorectal carcinoma.

T C Böttger1, D Potratz, M Stöckle, S Wellek, J Klupp, T Junginger.   

Abstract

BACKGROUND: Reported experiences regarding the prognostic significance of DNA content in colorectal carcinoma have been a matter of controversy.
METHODS: DNA analysis with image cytometry was performed in 137 patients with colorectal cancer. Only patients who had resection without tumor residual and who did not die postoperatively as a consequence of the operation were entered in the study. At the time of DNA analysis, neither the histomorphologic data nor the relapse-free survival time of the patients were known.
RESULTS: In this investigation the DNA content of tumor cells had no univariate or multivariate influence on the relapse-free survival time. The prognosis was dependent on the tumor localization, depth of tumor infiltration, lymph node metastasis, and grade.
CONCLUSIONS: DNA content provides no additional prognostic information in colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252471     DOI: 10.1002/1097-0142(19931215)72:12<3579::aid-cncr2820721206>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  HDAC2 and TXNL1 distinguish aneuploid from diploid colorectal cancers.

Authors:  Timo Gemoll; Uwe J Roblick; Silke Szymczak; Till Braunschweig; Susanne Becker; Bernd-Wolfgang Igl; Hans-Peter Bruch; Andreas Ziegler; Ulf Hellman; Michael J Difilippantonio; Thomas Ried; Hans Jörnvall; Gert Auer; Jens K Habermann
Journal:  Cell Mol Life Sci       Date:  2011-02-03       Impact factor: 9.261

2.  Stromal tenascin distribution as a prognostic marker in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Tomasini-Johansson; R Bergström; B Gerdin; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer.

Authors:  Timo Gemoll; Sarah Strohkamp; Katharina Schillo; Christoph Thorns; Jens K Habermann
Journal:  Oncotarget       Date:  2015-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.